Pharmafile Logo

ICON

Using Healthtech to Deliver Better Patient Outcomes

Peter Birch, General Manager (Asia Pacific) at MetaOptima Technologies & host of the “Talking HealthTech Podcast.” joins us to discuss a whole range of topics, including Peter’s professional journey and the...

Impetus Digital

If our patients are diverse, why are clinical trials so white?

Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue...

Blue Latitude Health

Impetus Digital Fireside Chat with Ryan Wiley, President of Shift Health

Ryan Wiley, President of Shift Health, discusses healthcare's journey towards digitalization and the ramifications COVID-19 has had in many of these areas. We also talk about Ryan's shift from academia to consulting...

Impetus Digital

We are COUCH Health

Making health human means that everything we do puts people first. __Pharmaceutical, biotech and life science companies turn to us to help them build strong connections with, and improve outcomes...

COUCH Health

https://vimeo.com/422463636

Demand Diversity Podcast

The unacceptable lack of diversity among clinical research participants would suggest that we are.As we begin our campaign to demand diversity in the clinical research space, we invite you to...

COUCH Health

- PMLiVE

Real-world studies

by Bill Row

- PMLiVE

UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

Invests in Genomics England alliance, plus clinical trials expansion

- PMLiVE

Key considerations for disease- modifying Parkinson’s disease trials

‘Lessons learnt from Alzheimer’s trials could help in Parkinson’s drug development’

- PMLiVE

Stakeholder dialogue in Europe’s adaptive pathways pilot

Is enhanced dialogue with wide stakeholder groups crucial to being able to respond to an unmet medical need?

- PMLiVE

Can a post-Brexit UK stay aligned with Europe on clinical research?

There's still no guarantee the UK can keep in step with EU

- PMLiVE

Almirall acquires Allergan’s dermatology portfolio for $650m

The pharma group buys four products along with Allergan's first-in-class antibiotic Seysara

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links